Analystreport

Prothena Co. PLC (NASDAQ: PRTA) had its "sell" rating re-affirmed by analysts at Barclays PLC. They now have a $9.00 price target on the stock.

Prothena Corporation plc - Ordinary Shares  (PRTA) 
Last prothena corporation plc - ordinary shares earnings: 2/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.prothena.com